Alpha 2.0
Login Register
» Authors » Athanasios Karampeazis

Athanasios Karampeazis

Explore the profile of Athanasios Karampeazis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 113
Followers 0
Related Specialties
Oncology
Pulmonary Medicine
Geriatrics
Top 10 Co-Authors
Vassilis Georgoulias
Lambros Vamvakas
Athanasios Kotsakis
Nikolaos Kentepozidis
Aris Polyzos
Nikolaos Vardakis
Dora Hatzidaki
Dimitris Mavroudis
Vassilis Chandrinos
Ioannis Boukovinas
Published In
J Geriatr Oncol
Clin Lung Cancer
Oncology
Cureus
Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group
Fiste O, Vamvakas L, Katsaounis P, Vardakis N, Kallianteri S, Georgoulias V, et al.
J Geriatr Oncol . 2025 Jan; 16(2):102184. PMID: 39787634
Introduction: The use of taxanes in the adjuvant setting of early breast cancer (BC) confers survival benefits, however, their role in older patients merits further study. This retrospective pooled analysis...
2.
Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives
Mizutani T, Cheung K, Hakobyan Y, Lane H, Decoster L, Karnakis T, et al.
J Geriatr Oncol . 2024 Feb; 15(2):101709. PMID: 38310661
Introduction: The Sustainable Development Goals of the United Nations include a commitment to "leave no one behind" as a universal goal. To achieve this in geriatric oncology (GO) worldwide, it...
3.
Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study
Galiti D, Linardou H, Agelaki S, Karampeazis A, Tsoukalas N, Psyrri A, et al.
Curr Oncol . 2023 Aug; 30(8):7608-7619. PMID: 37623032
Introduction: The increasing burden of cancer, the development of novel therapies, and the COVID-19 pandemic have made cancer care more complex. Digital innovation was then pushed toward developing platforms to...
4.
The Relevance and Added Value of Geriatric Medicine (GM): Introducing GM to Non-Geriatricians
Kotsani M, Kravvariti E, Avgerinou C, Panagiotakis S, Bograkou Tzanetakou K, Antoniadou E, et al.
J Clin Med . 2021 Jul; 10(14). PMID: 34300184
Geriatric Medicine (GM) holds a crucial role in promoting health and managing the complex medical, cognitive, social, and psychological issues of older people. However, basic principles of GM, essential for...
5.
Propranolol and Weekly Paclitaxel in the Treatment of Metastatic Heart Angiosarcoma
Fiste O, Dimos A, Kardara V, Ballasis K, Karampeazis A
Cureus . 2021 Feb; 12(12):e12262. PMID: 33520481
Heart angiosarcoma, the most frequent among cardiac malignancies, is an extremely rare vascular tumor known to carry a dismal prognosis. The spectrum of presenting symptoms depends on tumor's size, its...
6.
Malignant Transformation of Schneiderian Papilloma Presenting With Progressive Binocular Diplopia and Blepharoptosis
Fiste O, Tsiogka A, Arvanitou E, Karampeazis A, Christofyllakis C
Cureus . 2020 Oct; 12(9):e10514. PMID: 33094055
Sinonasal tumors arising from Schneiderian papillomas, most frequently associated with squamous cell carcinoma (SCC), are rare and often present with non-specific symptoms, even in an advanced stage. Herein, we report...
7.
Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)
Asimakopoulou N, Souglakos J, Kentepozidis N, Karampeazis A, Kotsakis A, Ziras N, et al.
J Geriatr Oncol . 2018 Oct; 10(1):143-148. PMID: 30366852
Background: Although colorectal cancer (CRC) is a disease of the older patients, older patients are under-represented from randomized trials. Herein we conducted a retrospective analysis for the effect of panitumumab...
8.
Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group
Karampeazis A, Vamvakas L, Kentepozidis N, Polyzos A, Chandrinos V, Rigas G, et al.
Clin Lung Cancer . 2016 Jul; 17(6):543-549. PMID: 27397849
Background: The present study was a phase I/II study to determine the maximum tolerated doses (MTDs) and dose-limiting toxicities of the biweekly carboplatin/gemcitabine combination and evaluate its safety and efficacy...
9.
Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study
Karampeazis A, Vamvakas L, Kotsakis A, Christophyllakis C, Kentepozidis N, Chandrinos V, et al.
J Geriatr Oncol . 2016 Jun; 8(1):23-30. PMID: 27264267
Objectives: To compare first-line treatment with docetaxel plus gemcitabine (DG) versus gemcitabine (G) in elderly patients with advanced/metastatic non-small-cell lung cancer (NSCLC). Patients And Methods: Chemotherapy-naïve patients with inoperable stage...
10.
Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review
Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, et al.
Oral Surg Oral Med Oral Pathol Oral Radiol . 2015 Oct; 120(6):699-706. PMID: 26455289
Objective: We present clinical and radiologic data of periodontal tissue involvement preceding the appearance of osteonecrosis of the jaw (ONJ) in 5 patients with solid tumors, who received antiresorptives alone...